Results for tag: "Fampyra"

Fampyra (fampridine) is a cardiovascular drug used to treat multiple sclerosis (MS). It is a potassium channel blocker that helps improve walking ability in people with MS. Fampyra is approved in the United States, Europe, and other countries for the treatment of MS. It is also used off-label to treat other neurological conditions such as spinal cord injury, cerebral palsy, and stroke. The Fampyra market is a rapidly growing segment of the cardiovascular drug market. It is estimated that the global Fampyra market will reach $1.2 billion by 2027, driven by the increasing prevalence of MS and other neurological conditions. The market is also driven by the increasing availability of generic versions of the drug, which are more affordable than the branded version. Some of the major companies in the Fampyra market include Acorda Therapeutics, Biogen, Merck, Novartis, and Teva Pharmaceuticals. These companies are involved in the development, manufacturing, and marketing of Fampyra and other related drugs. Show Less Read more